INDEGENE LIMITED (INDGN.NS)
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally.
515.15+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-10.8%
The outlook
INDEGENE LIMITED currently reads as leaning bullish based on buy — 1.6 avg of 8 analysts, above its 50- & 200-day averages, 55% of the way from its 52-week low to high, avg target +18% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.6 avg of 8 analysts
Price trendAbove its 50- & 200-day averages
52-week range55% of the way from its 52-week low to high
Price targetAvg target +18% vs current price
Analyst price target
~12-month · 8 analysts607.13average target+17.9% vs now
Now 515.15
Low 500.00High 705.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$123.91B
52-wk high
596.80
52-wk low
414.00
50-day avg
513.11
200-day avg
502.89
Trailing P/E
31.0